GCA
CDMO

Greenwood Capital Associates’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Greenwood Capital Associates’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-31,188
Closed -$294K – 275
2023
Q3 		$294K Sell
31,188
-27,493
-47% -$331K 0.04% 224
2023
Q2 		$820K Sell
58,681
-8,892
-13% -$152K 0.12% 147
2023
Q1 		$1.27M Sell
67,573
-2,585
-4% -$42.5K 0.18% 109
2022
Q4 		$966K Buy
70,158
+7,011
+11% +$107K 0.16% 111
2022
Q3 		$1.21M Sell
63,147
-895
-1% -$16.3K 0.21% 96
2022
Q2 		$977K Sell
64,042
-5,403
-8% -$79.9K 0.16% 115
2022
Q1 		$1.42M Buy
69,445
+4,300
+7% +$87.6K 0.37% 47
2021
Q4 		$1.9M Sell
65,145
-17,292
-21% -$495K 0.27% 71
2021
Q3 		$1.78M Buy
82,437
+51
+0.1% +$1.23K 0.27% 74
2021
Q2 		$2.11M Sell
82,386
-993
-1% -$21.2K 0.32% 68
2021
Q1 		$1.52M Sell
83,379
-7,264
-8% -$121K 0.24% 79
2020
Q4 		$1.05M Buy
90,643
+21,966
+32% +$201K 0.18% 100
2020
Q3 		$523K Buy
+68,677
New +$520K 0.1% 117

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Greenwood Capital Associates's CDMO Position: Q4 2023 in Review

Greenwood Capital Associates sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 31,188 shares — an estimated $294K sold.

Greenwood Capital Associates first reported a position in CDMO in Q3 2020 and held it in 13 quarters. The position peaked at $2.11M in Q2 2021. 175 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

  • Greenwood Capital Associates reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Greenwood Capital Associates sold 31,188 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $294K.
  • Greenwood Capital Associates first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • Greenwood Capital Associates's Avid Bioservices, Inc. Common Stock position peaked at $2.11M in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Greenwood Capital Associates's 13F filing for Q4 2023, filed 5 Mar 2024.